CELLUMED Postpones Extraordinary General Meeting from April 30 to May 11, Neutral Disclosure on Schedule Change


  • The extraordinary general meeting date has been postponed from April 30, 2026 to May 11, 2026.
  • Detailed agenda items have not been finalized; they will be determined by the board and disclosed later.
  • [AI Summary]This is purely a schedule change with no direct impact on shareholder value, thus evaluated as neutral.

KOSDAQ Filing Information


  • Filing: [Correction of Description] Resolution on Convening of General Meeting of Shareholders (Extraordinary General Meeting)
  • Company: CELLUMED (049180)
  • Submission: CELLUMED CO., LTD.
  • Receipt: 04-15-2026
  • Under KRX KOSDAQ Market Division, Amended (Refer to related filing)